Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence. Go to Publication You Might Also Like Early bactericidal activity of new drug regimens for tuberculosis. January 12, 2013 Disseminated tuberculosis with immune thrombocytopenic purpura. January 29, 2012 Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. May 21, 2017 Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables. March 6, 2016 ‘Universal’ access for MDR-TB limited without the involvement of the private sector. January 10, 2011
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. May 21, 2017
Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables. March 6, 2016
‘Universal’ access for MDR-TB limited without the involvement of the private sector. January 10, 2011